Showing 2831-2840 of 8635 results for "".
Open Access: Thoughts for the Ballot Box
https://practicaldermatology.com/topics/practice-management/open-access-thoughts-for-the-ballot-box/20908/Access to drugs, derms at stake in US presidential election.Breaking the Red Tape: The AMA and Meaningful Use
https://practicaldermatology.com/topics/practice-management/breaking-the-red-tape-the-ama-and-meaningful-use/21096/Discourse and Education Key to Growth in the Aesthetic Spectrum
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/discourse-and-education-key-to-growth-in-the-aesthetic-spectrum/21237/Update On the Use of Spironolactone to Treat Adult Female Acne
https://practicaldermatology.com/topics/general-topics/update-on-the-use-of-spironolactone-to-treat-adult-female-acne/20917/There is a role for spironolactone in some adult female acne patients.New Products
https://practicaldermatology.com/columns/new-products/new-products/20668/Digital Photomapping (DPM) in Mohs
https://practicaldermatology.com/topics/general-topics/digital-photomapping-dpm-in-mohs/20682/High Risk SCC: What Factors Predict Recurrence and Metastasis?
https://practicaldermatology.com/topics/general-topics/PD1208_12-php/22609/Data shed light on risk factors associated with aggressive SCC, allowing dermatologists to identify and properly follow high-risk patients.New Products and Pharmacological Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacological-developments/20345/Monitoring Biologic Therapy In Psoriasis: A Primer
https://practicaldermatology.com/topics/psoriasis/monitoring-biologic-therapy-in-psoriasis-a-primer/20931/Treatments are generally safe and well-tolerated, however, prescribers must monitor for risk factors.The Role of Inflammation in Acne Vulgaris
https://practicaldermatology.com/topics/general-topics/the-role-of-inflammation-in-acne-vulgaris/21512/Multiple lines of evidence support a pivotal role for inflammation in the pathogenesis of acne vulgaris.